drugset / Trial / NCT06067568
Relative Bioavailability of Two Lutikizumab Formulations and Pharmacokinetics, Safety, and Tolerability of Lutikizumab in Chinese Participants
RandomizedSequentialOpen-labelBasic science
Summary
The purpose of this study is to compare the bioavailability of two different formulations of lutikizumab, and to assess adverse events (AEs) and how lutikizumab moves through the body in healthy Chinese participants.
Timeline
- Start
- 2023-09-28
- Primary completion
- 2024-02-26
- Completion
- 2024-02-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lutikizumab | Monoclonal antibody | — | Subcutaneous |
Indications
No indication recorded.